Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Strebel

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Virology|December 15, 2015
Low dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1Sarah Welbourn, Klaus Strebel
Retrovirology|June 26, 2008
HIV-1 Vif, APOBEC, and intrinsic immunityRitu Goila-Gaur, Klaus Strebel
BMC Microbiology|January 8, 2017
Pyviko: an automated Python tool to design gene knockouts in complex viruses with overlapping genesLouis J Taylor, Klaus Strebel
Retrovirology|July 4, 2008
APOBEC3G encapsidation into HIV-1 virions: which RNA is it?Klaus Strebel, Mohammad A Khan
Journal of Virology|October 11, 2013
Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactionsTakeshi Yoshida, Yoshio Koyanagi, Klaus Strebel
Frontiers in Microbiology|June 21, 2011
Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function ApproachTakeshi Yoshida, Sandra Kao, Klaus Strebel
Journal of Virology|December 31, 2010
Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherinAmy J Andrew, Eri Miyagi, Klaus Strebel
The Journal of Biological Chemistry|September 23, 2011
C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motifAmy J Andrew, Sandra Kao, Klaus Strebel
BMC Medicine|September 18, 2009
Human cellular restriction factors that target HIV-1 replicationKlaus Strebel, Jeremy Luban, Kuan-Teh Jeang
Virology|May 3, 2003
Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle releaseStephan Bour, Hirofumi Akari, Eri Miyagi, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Virology|December 15, 2015
Low dNTP levels are necessary but may not be sufficient for lentiviral restriction by SAMHD1Sarah Welbourn, Klaus Strebel
Retrovirology|June 26, 2008
HIV-1 Vif, APOBEC, and intrinsic immunityRitu Goila-Gaur, Klaus Strebel
BMC Microbiology|January 8, 2017
Pyviko: an automated Python tool to design gene knockouts in complex viruses with overlapping genesLouis J Taylor, Klaus Strebel
Retrovirology|July 4, 2008
APOBEC3G encapsidation into HIV-1 virions: which RNA is it?Klaus Strebel, Mohammad A Khan
Journal of Virology|October 11, 2013
Functional antagonism of rhesus macaque and chimpanzee BST-2 by HIV-1 Vpu is mediated by cytoplasmic domain interactionsTakeshi Yoshida, Yoshio Koyanagi, Klaus Strebel
Frontiers in Microbiology|June 21, 2011
Identification of Residues in the BST-2 TM Domain Important for Antagonism by HIV-1 Vpu Using a Gain-of-Function ApproachTakeshi Yoshida, Sandra Kao, Klaus Strebel
Journal of Virology|December 31, 2010
Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherinAmy J Andrew, Eri Miyagi, Klaus Strebel
The Journal of Biological Chemistry|September 23, 2011
C-terminal hydrophobic region in human bone marrow stromal cell antigen 2 (BST-2)/tetherin protein functions as second transmembrane motifAmy J Andrew, Sandra Kao, Klaus Strebel
BMC Medicine|September 18, 2009
Human cellular restriction factors that target HIV-1 replicationKlaus Strebel, Jeremy Luban, Kuan-Teh Jeang
Virology|May 3, 2003
Naturally occurring amino acid substitutions in the HIV-2 ROD envelope glycoprotein regulate its ability to augment viral particle releaseStephan Bour, Hirofumi Akari, Eri Miyagi, et al.
Pageof 10